DE3367328D1 - Pharmaceutical composition comprising immune globulin and fibronectin - Google Patents

Pharmaceutical composition comprising immune globulin and fibronectin

Info

Publication number
DE3367328D1
DE3367328D1 DE8383105957T DE3367328T DE3367328D1 DE 3367328 D1 DE3367328 D1 DE 3367328D1 DE 8383105957 T DE8383105957 T DE 8383105957T DE 3367328 T DE3367328 T DE 3367328T DE 3367328 D1 DE3367328 D1 DE 3367328D1
Authority
DE
Germany
Prior art keywords
fibronectin
immune globulin
pharmaceutical composition
produce
amounts sufficient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383105957T
Other languages
English (en)
Inventor
John L Lundblad
Miriam D Budinger
Richard S Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Application granted granted Critical
Publication of DE3367328D1 publication Critical patent/DE3367328D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8383105957T 1982-07-02 1983-06-18 Pharmaceutical composition comprising immune globulin and fibronectin Expired DE3367328D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/394,977 US4412990A (en) 1982-07-02 1982-07-02 Composition having enhanced opsonic activity

Publications (1)

Publication Number Publication Date
DE3367328D1 true DE3367328D1 (en) 1986-12-11

Family

ID=23561169

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383105957T Expired DE3367328D1 (en) 1982-07-02 1983-06-18 Pharmaceutical composition comprising immune globulin and fibronectin

Country Status (7)

Country Link
US (1) US4412990A (de)
EP (1) EP0098431B1 (de)
JP (1) JPS5920229A (de)
AT (1) ATE23270T1 (de)
CA (1) CA1208555A (de)
DE (1) DE3367328D1 (de)
ES (1) ES523795A0 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122267A4 (de) * 1982-10-21 1986-09-24 Minneapolis Medical Res Founda Opsonine in peritonealer dialyse.
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
US4894328A (en) * 1986-03-26 1990-01-16 Board Of Regents, The University Of Texas System Immunodiagnostic test for syphilis and other treponemal infections
CA1310267C (en) * 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
JP2547556B2 (ja) * 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US7238668B1 (en) * 1989-09-01 2007-07-03 Fred Hutchinson Cancer Research Center Inhibition of lymphocyte adherence with CS-1-peptides and fragments thereof
US20080139789A1 (en) * 1990-10-22 2008-06-12 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
EP0680337A4 (de) * 1993-01-12 1997-07-30 Anthony George Gristina Methoden und zusammensetzungen zur direkter konzentrierter verabreichung passiver immunität.
JP2000516911A (ja) * 1996-03-28 2000-12-19 ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ オプソニン強化細胞、および抗原に対する免疫応答を調節する方法
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
EP2625577B1 (de) 2010-10-08 2019-06-26 Terumo BCT, Inc. Anpassbares verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem
CN104053670A (zh) 2011-10-31 2014-09-17 百时美施贵宝公司 具有降低的免疫原性的纤连蛋白结合域
US10633625B2 (en) 2013-11-16 2020-04-28 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3122866B1 (de) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passives ersetzen von medien
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3601521A2 (de) 2017-03-31 2020-02-05 Terumo BCT, Inc. Zellexpansion
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2848529A1 (de) * 1978-11-09 1980-05-29 Behringwerke Ag Verfahren zur herstellung des kaelteunloeslichen globulins und dieses enthaltende arzneimittel
EP0035204B2 (de) * 1980-03-05 1991-05-22 Miles Inc. Pasteurisierte therapeutisch aktive Proteinzusammensetzungen

Also Published As

Publication number Publication date
ES8504462A1 (es) 1985-04-16
EP0098431B1 (de) 1986-11-05
ATE23270T1 (de) 1986-11-15
CA1208555A (en) 1986-07-29
ES523795A0 (es) 1985-04-16
JPS5920229A (ja) 1984-02-01
JPH0585525B2 (de) 1993-12-07
EP0098431A2 (de) 1984-01-18
US4412990A (en) 1983-11-01
EP0098431A3 (en) 1984-09-12

Similar Documents

Publication Publication Date Title
DE3367328D1 (en) Pharmaceutical composition comprising immune globulin and fibronectin
GB2071670B (en) Nutrient compositions and methods of administering the same
DE3569188D1 (en) A method of making a food composition containing inositoltriphosphate and the composition
EP0129778A3 (en) Cell-stimulating composition
GB1534823A (en) Dental chairs or like patient supporting devices
IL103981A0 (en) Pharmaceutical compositions for treatment of multiple sclerosis
PT76314A (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
HK129695A (en) Improvements in or relating to antiprotozoal agents
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
DE3165600D1 (en) Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
ZA855306B (en) Use of lycorine as an immunosuppressor
NZ224116A (en) Compositions of interleukin-2 and fk565; method of stimulation of the immune system and package
HUT64691A (en) Cosmetic preparative with skin regenerative effect
ZA855822B (en) Pharmaceutical compositions for the treatment of involutional brain syndromes and mental decay
ES2009249A6 (es) Composicion cosmetica regeneradora de la piel a base de algas que contengan selenio.
JPS5721354A (en) Esters of carnitine alkoxy-acyl derivatives, manufacture and medicinal composition as effective component thereof
JPS55113721A (en) Immunity regulator
ZA833997B (en) Basic esters exhibiting an antagonistic activity to calcium,process for the preparation thereof and pharmaceutical compositions therefrom
DE3572187D1 (en) Additive-containing paints
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
DE3474897D1 (en) Timed release delivery means for delivery of active agent to spatially separated terrain locations and compositions comprised thereby
SE8300495D0 (sv) Improvements in or relating to nasal pharmaceutical compositions
OA09771A (en) Asphodelus composition for increasing white blood cell count.
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
HUT34445A (en) Process for producing 1-phenoxy-3-/hydroxy-indolyl-alkyl-amino/-"aepropanoles and pharmaceutical compositions containing them as active ingredients

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee